Signaling pathways
-
BA8504 DesmethoxyyangoninSummary: MAO-B reversible inhibitor. -
BA8508 ToloxatoneSummary: Toloxatone (MD69276) is a reversible monoamine oxidase A inhibitor. - BA8509 LazabemideSummary: Lazabemide (Ro19-6327) is a selective and reversible inhibitor of monoamine oxidase B (MAO-B) (=0.03 μM), but is less active against (IC>100 μM).
- BA8510 MAO-B-IN-25Summary: A selective inhibitor.
- BA8511 PXS-5120ASummary: PXS-5120A is a potent, irreversible fluorinated allylamine inhibitor with antifibrotic activity.
- BA8512 TisolagilineSummary: Tisolagiline (KDS2010) is a reversible inhibitor.
- BA8513 ObtusinSummary: Obtusin is derived from cassia seeds and is a highly selective and competitive inhibitor of human monoamine oxidase-A.
- BA8514 GlicoriconeSummary: Glicoricone is a phenolic compound isolated from licorice.
- BA8515 BrofaromineSummary: Brofaromine (CGP11305A) is a monoamine oxidase inhibitor.
- BA8516 CAD031Summary: CAD031 is a derivative of the Alzheimer's disease (AD)-targeting agent J147 with neuroprotective and memory-enhancing properties.